Announcing the Commercial Availability of A/H7N9 Influenza Rapid Subtyping Test in Japan for Research Use Only (RUO)
Recently, a new avian influenza A/H7N9 strain emerged in China with 135 confirmed cases and over 40 related deaths as of August 2013. The first case of human-to-human transmission of A/H7N9 influenza was documented and resulted in death. This rapid emergence of a new strain of bird flu including 3 newly confirmed human cases in China since August has sparked worldwide concerns of a possible pandemic and a need for a containment strategy. Arbor Vita’s A/H7N9 Influenza Rapid Subtyping Test detects the NS1 protein, an early and abundantly expressed biomarker. The availability of Arbor Vita’s A/H7N9 Influenza Rapid SubtypingTest at strategic locations including border entry points, airports, harbors, aboard vessels, at other high-density population areas and at select food processing centers, will allow early detection, identification and isolation of A/H7N9 infected individuals.